Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE KIBARI ET ASSOCIES : revenue, balance sheet and financial ratios

SELARL PHARMACIE KIBARI ET ASSOCIES is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CHARTRES (28000), this company of category PME shows in 2025 a net income positive of 15 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE KIBARI ET ASSOCIES (SIREN 983331091)
Indicator 2025
Revenue N/C
Net income 15 389 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2025, SELARL PHARMACIE KIBARI ET ASSOCIES generates positive net income of 15 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

15 389 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1015%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1015.129%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

7.05%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

79.0%

Solvency indicators evolution
SELARL PHARMACIE KIBARI ET ASSOCIES

Sector positioning

Debt ratio
1015.13 2025
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch

In 2025, the debt ratio of SELARL PHARMACIE KIBARI E... (1015.13) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
7.05% 2025
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch

In 2025, the financial autonomy of SELARL PHARMACIE KIBARI E... (7.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 259.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

259.012

Liquidity indicators evolution
SELARL PHARMACIE KIBARI ET ASSOCIES

Sector positioning

Liquidity ratio
259.01 2025
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent

In 2025, the liquidity ratio of SELARL PHARMACIE KIBARI E... (259.01) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE KIBARI ET ASSOCIES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE KIBARI ET ASSOCIES is estimated at 244 456 € (range 165 889€ - 383 585€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
165k€ 244k€ 383k€
244 456 € Range: 165 889€ - 383 585€
NAF 5 année 2025

Valuation method used

Net Income Multiple
15 389 € × 15.9x = 244 456 €
Range: 165 889€ - 383 585€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE KIBARI ET ASSOCIES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE KIBARI ET ASSOCIES

What is the revenue of SELARL PHARMACIE KIBARI ET ASSOCIES ?

The revenue of SELARL PHARMACIE KIBARI ET ASSOCIES is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE KIBARI ET ASSOCIES profitable?

Yes, SELARL PHARMACIE KIBARI ET ASSOCIES generated a net profit of 15 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE KIBARI ET ASSOCIES ?

The headquarters of SELARL PHARMACIE KIBARI ET ASSOCIES is located in CHARTRES (28000), in the department Eure-et-Loir.

Where to find the tax return of SELARL PHARMACIE KIBARI ET ASSOCIES ?

The tax return of SELARL PHARMACIE KIBARI ET ASSOCIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE KIBARI ET ASSOCIES operate?

SELARL PHARMACIE KIBARI ET ASSOCIES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.